|
|
|
| Basic information |
|
| Name |
Mizutani Yuko |
| Belonging department |
|
| Occupation name |
|
| researchmap researcher code |
7000027157 |
| researchmap agency |
Okayama University of Science |
Palliative effects of non-selective intra-arterial chemotherapy of paclitaxel plus platinum combination in two dogs with intranasal cancers
日高 勇一, 小池 貢史, 三角 瞬, 吉川 理紗, 小西 祐子, 佐藤 裕之, 平井 卓哉, 三堂 祥吾, 堀井 洋一郎, 都築 直, 萩尾 光美
|
 |
Non-selective intra-arterial (I-A) chemotherapy of paclitaxel plus platinum combination was performed in two dogs with
cancers of the nasal cavity, including undifferentiated (Case 1) and transitional (Case 2) carcinomas. The drug dosages
were reduced to 25% to 35.5% of the typical doses for systemic chemotherapy, and they were perfused via common
carotid arteries. Case 1 had marked regression of the cancer but survived for only 53 days after the therapy. Case 2 had
partial remission for approximately 3 months and survived for 126 days. Adverse events of the chemotherapies were not
induced in Case 1, but mild adverse events were seen in Case 2. Non-selective I-A chemotherapy in this report required
easy and simple procedures and could be safely performed via a reduction of the dosages of the drugs. Although future
research will address issues concerning the intervals, frequencies, and drug dosages, the I-A chemotherapy was suggested
as being able to contribute to palliative remission in canine intranasal cancers.
|
